Insider Transactions in Q1 2022 at Esperion Therapeutics, Inc. (ESPR)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2022
|
Sheldon L. Koenig President and CEO |
SELL
Open market or private sale
|
Direct |
571
-0.29%
|
$2,284
$4.58 P/Share
|
|
Mar 14
2022
|
Sheldon L. Koenig President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
116,000
+37.26%
|
-
|
|
Mar 14
2022
|
Richard Bartram Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,000
+30.9%
|
-
|
|
Mar 14
2022
|
Joanne M. Foody Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+19.86%
|
-
|
|
Mar 14
2022
|
Eric Warren Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,000
+19.37%
|
-
|
|
Jan 27
2022
|
Benjamin Looker General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
70,800
+50.0%
|
-
|